Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)

v3.23.1
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance, amount at Dec. 31, 2021 $ (17,286,423) $ 23,524 $ 16,380,597 $ (33,543,351) $ (147,193)
Beginning balance, shares at Dec. 31, 2021   23,523,969      
Net income (loss) (13,962)     (13,962)  
Foreign currency translation gain (loss) (41,949)       (41,949)
Stock options exercised 195,456 $ 220 195,236    
Stock options exercised, share   219,999      
Share-based compensation 310,002 $ 19 309,983    
Share based compensation, share   18,965      
Ending balance, amount at Mar. 31, 2022 (16,836,876) $ 23,763 16,885,816 (33,557,313) (189,142)
Ending balance, shares at Mar. 31, 2022   23,762,933      
Beginning balance, amount at Dec. 31, 2022 (17,885,387) $ 24,411 17,575,396 (35,316,540) (168,654)
Beginning balance, shares at Dec. 31, 2022   24,411,098      
Net income (loss) 110,694     110,694  
Foreign currency translation gain (loss) 16,637       16,637
Share-based compensation 244,923 $ 28 244,895    
Share based compensation, share   27,392      
Ending balance, amount at Mar. 31, 2023 $ (17,513,133) $ 24,439 $ 17,820,291 $ (35,205,846) $ (152,017)
Ending balance, shares at Mar. 31, 2023   24,438,490